A pill developed by GSK was found to be safe and effective in treating gonorrhea in a late-stage clinical trial, according to ...

A new class of antibiotic has been found to be safe and effective in treating gonorrhea in late-stage trials, according to a ...

London: British pharmaceutical major GlaxoSmithKline (GSK) has failed to meet the required regulatory and ethical standards ...

Antibiotic resistance is a major threat to human health. But experts say there are steps people can take to reduce the risk.

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial, ...

Health experts have worried for some time what might happen if a new form of gonorrhea develops that doesn’t respond to our ...

The drug is manufactured by the pharmaceutical company GSK and is sold under the name Blujepa. After reaching a historic low in 2009, cases of gonorrhea in the United States steadily increased ...

The drug is sold under the name Blujepa. A new treatment option is important, experts say, because bacteria that commonly cause STIs are increasingly becoming resistant to the standard antibiotics ...

Gepotidacin, sold as Blujepa, is a first-in-class triazaacenaphthylene antibiotic that acts by inhibiting bacteria’s replication of DNA. In a late-stage, multi-nation trial, researchers randomly ...

Gepotidacin, sold as Blujepa, is a first-in-class triazaacenaphthylene antibiotic that acts by inhibiting bacteria's replication of DNA. In a late-stage, multi-nation trial, researchers randomly ...